Common FDA Bioresearch Monitoring Violations: Updates from FY 2022 to Now
The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits ...
The Bioresearch Monitoring (BIMO) Program, operated by the U.S. Food and Drug Administration (FDA), conducts on-site inspections and data audits ...
On May 2, 2023, the U.S. Food and Drug Administration (“FDA”) published draft guidance titled “Decentralized Clinical Trials for Drugs, ...
The U.S. Food and Drug Administration (FDA) recently finalized its guidance, “A Risk-Based Approach to Monitoring of Clinical Investigations” (the ...
CLIMATEWIRE | DUBAI, United Arab Emirates — Now the real work starts.The first few days of the COP28 climate conference featured...
Read moreDigital health company Celero Systems is developing an electronic pill that can measure heart rate, breathing rate, and core temperature—from...
Read moreA new review suggests that having a cat as a pet could potentially double a person's risk of schizophrenia-related disorders.Australian...
Read moreWinter School– A School of Unlearning Department of Bioanalytical Sciences & Department of Zoology Organizes a National Workshop on ‘Vocational and Skill Based...
Read more© Life Sciences News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Life Sciences News Hubb All rights reserved.